Health AI Central
Share:
Peer-Reviewed Publication
Blood Adv2026;10(3):604-607.February 10, 2026Journal Article

Long-term remission after cilta-cel in multiple myeloma is linked to diverse T cells and low myeloid suppression.

Junia Vieira Dos Santos1, David T Melnekoff2,3, Adolfo Aleman2,3,4, Tarek H Mouhieddine3,4, Rocio Montes de Oca5, Feng Wang6, Sridevi Rajeeve3,4, Sherry Bhalla4, Oliver Van Oekelen3,4, Bhaskar Upadhyaya3,4, Yogita Ghodke-Puranik3,4, Violetta Leshchenko3,4, Seunghee Kim-Schulze3,7,8, Adeeb Rahman9, Shaked Afik9, Hadas Lewinsky9, Vicki Plaks5, Santiago Thibaud3,4, Hearn Jay Cho3,4, Joshua Richter3,4, Cesar Rodriguez3,4, Larysa Sanchez3,4, Adriana Rossi3,4, Shambavi Richard3,4, Ajai Chari3,4, Deepu Madduri1, Sundar Jagannath3,4, Samir Parekh1,3,4, Alessandro Laganà1,4,10
1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
2Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
3Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.
4Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
5Johnson & Johnson, Spring House, PA.
6Johnson & Johnson, Shanghai, China.
7The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
8Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY.
9Immunai, New York, NY.
10Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
PubMed PMC DOI PDF

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.